Pharmaceutical composition and application thereof in preparation of products for treating prostatitis
A prostatitis and composition technology, applied in the field of biotechnology and pharmaceutical preparation, can solve the problems that the prostatitis field involves less, lycopene, quercetin and curcumin combined drug research has not been reported in literature, etc. Effect, effect of reducing dosage, reducing production cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0059] Embodiment 1, the pharmaceutical composition that lycopene, quercetin and curcumin form and preparation thereof
[0060] The pharmaceutical composition is made of the following components in parts by mass:
[0061] 1 part lycopene;
[0062]1 part quercetin;
[0063] Curcumin 1 part.
[0064] A medicine is prepared from the above-mentioned pharmaceutical composition as an active ingredient, and the dosage form is an oral preparation, which is a suspension.
[0065] The preparation method of the above drug suspension comprises the following steps: 1) the lycopene suspension is prepared by dissolving lycopene in corn oil, and the concentration is 10 mg / ml;
[0066] The quercetin suspension is prepared by dissolving quercetin in 25% hydroxypropyl-β-cyclodextrin mother liquor with a concentration of 10 mg / ml;
[0067] The curcumin suspension is prepared by dissolving curcumin in 25% hydroxypropyl-β-cyclodextrin mother liquor with a concentration of 10 mg / ml;
[0068] Th...
Embodiment 2
[0070] Embodiment 2, lycopene, quercetin and curcumin are used in combination to treat prostatitis animal model
[0071] 1. Construction of rat chronic nonbacterial prostatitis model ("Replication of Rat Nonbacterial Prostatitis Model", Yang Xiaorong et al., Experimental and Laboratory Medicine)
[0072] 1) Experimental animals: 30 male SD rats aged 6-8 weeks, weighing 260-280 g, were fed for 1 week before the experiment.
[0073] 2) Grouping of animals: randomly divided into normal group, model group, lycopene treatment group, quercetin treatment group, curcumin treatment group and combined drug group (i.e. lycopene, quercetin and curcumin combined drug group, It is the medicine prepared in Example 1 of the present invention), 6 in each group.
[0074] 3) Construct rat chronic non-bacterial prostatitis model: model group and 4 treatment groups (namely lycopene treatment group, quercetin treatment group, curcumin treatment group and combination drug group) rats, with 6% hydra...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


